Publications by authors named "E S Lambright"

The double-stapled () anastomotic technique associates with lower odds of anastomotic leak and stricture. , Single posterior stapled.

View Article and Find Full Text PDF
Article Synopsis
  • Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is used for support during lung transplants, but the ideal level of anticoagulation needed to balance thromboembolism risk and bleeding is not established.
  • A study analyzed 163 patients, categorizing anticoagulation intensity into four levels based on heparin doses, to evaluate blood transfusion rates and thromboembolism occurrences.
  • Results indicated that higher anticoagulation intensity correlated with increased blood transfusions, while thromboembolism rates remained similar across all groups, suggesting that lower anticoagulation might be beneficial in reducing transfusions, but further research is required.
View Article and Find Full Text PDF

Background: Appropriate risk stratification of indeterminate pulmonary nodules (IPNs) is necessary to direct diagnostic evaluation. Currently available models were developed in populations with lower cancer prevalence than that seen in thoracic surgery and pulmonology clinics and usually do not allow for missing data. We updated and expanded the Thoracic Research Evaluation and Treatment (TREAT) model into a more generalized, robust approach for lung cancer prediction in patients referred for specialty evaluation.

View Article and Find Full Text PDF

Background: Patients who are symptomatic from diaphragmatic dysfunction may benefit from diaphragmatic plication. We recently modified our plication approach from open thoracotomy to robotic transthoracic. We report our short-term outcomes.

View Article and Find Full Text PDF

Unlabelled: Donor-derived cell-free DNA (dd-cfDNA) is a useful biomarker for the diagnosis of acute allograft injury within the first 1 to 2 y after lung transplant, but its utility for diagnosing chronic lung allograft dysfunction (CLAD) has not yet been studied. Understanding baseline dd-cfDNA kinetics beyond the initial 2 y posttransplant is a necessary first step in determining the utility of dd-cfDNA as a CLAD biomarker. We seek to establish baseline dd-cfDNA% levels in clinically stable lung allograft recipients who are >2 y posttransplant.

View Article and Find Full Text PDF